Your browser doesn't support javascript.
loading
Medical countermeasures during the 2018 Ebola virus disease outbreak in the North Kivu and Ituri Provinces of the Democratic Republic of the Congo: a rapid genomic assessment.
Mbala-Kingebeni, Placide; Aziza, Amuri; Di Paola, Nicholas; Wiley, Michael R; Makiala-Mandanda, Sheila; Caviness, Katie; Pratt, Catherine B; Ladner, Jason T; Kugelman, Jeffrey R; Prieto, Karla; Chitty, Joseph A; Larson, Peter A; Beitzel, Brett; Ayouba, Ahidjo; Vidal, Nicole; Karhemere, Stomy; Diop, Mamadou; Diagne, Moussa M; Faye, Martin; Faye, Ousmane; Aruna, Aaron; Nsio, Justus; Mulangu, Felix; Mukadi, Daniel; Mukadi, Patrick; Kombe, John; Mulumba, Anastasie; Villabona-Arenas, Christian-Julian; Pukuta, Elisabeth; Gonzalez, Jeanette; Bartlett, Maggie L; Sozhamannan, Shanmuga; Gross, Stephen M; Schroth, Gary P; Tim, Roger; Zhao, Junhua J; Kuhn, Jens H; Diallo, Boubacar; Yao, Michel; Fall, Ibrahima S; Ndjoloko, Bathe; Mossoko, Mathias; Lacroix, Audrey; Delaporte, Eric; Sanchez-Lockhart, Mariano; Sall, Amadou A; Muyembe-Tamfum, Jean-Jacques; Peeters, Martine; Palacios, Gustavo; Ahuka-Mundeke, Steve.
Afiliação
  • Mbala-Kingebeni P; Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo; TransVIHMI, Institut de Recherche pour le Développement, Institut National de la Santé et de la Recherche Médicale, Université de Montpellier, Montpellier, France; Service de Microbiologie, Cliniques Universitair
  • Aziza A; Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo.
  • Di Paola N; Center for Genome Sciences, United States Army Medical Research Institute of Infectious Diseases, Frederick, MD, USA.
  • Wiley MR; Center for Genome Sciences, United States Army Medical Research Institute of Infectious Diseases, Frederick, MD, USA; College of Public Health, Northern Arizona University, Flagstaff, AZ, USA.
  • Makiala-Mandanda S; Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo; Service de Microbiologie, Cliniques Universitaires de Kinshasa, Kinshasa, Democratic Republic of the Congo.
  • Caviness K; Center for Genome Sciences, United States Army Medical Research Institute of Infectious Diseases, Frederick, MD, USA.
  • Pratt CB; Center for Genome Sciences, United States Army Medical Research Institute of Infectious Diseases, Frederick, MD, USA; College of Public Health, Northern Arizona University, Flagstaff, AZ, USA.
  • Ladner JT; University of Nebraska Medical Center, Omaha, NE, USA; The Pathogen and Microbiome Institute, Northern Arizona University, Flagstaff, AZ, USA.
  • Kugelman JR; Command and General Staff College, Fort Leavenworth, KS, USA.
  • Prieto K; Center for Genome Sciences, United States Army Medical Research Institute of Infectious Diseases, Frederick, MD, USA; College of Public Health, Northern Arizona University, Flagstaff, AZ, USA.
  • Chitty JA; Center for Genome Sciences, United States Army Medical Research Institute of Infectious Diseases, Frederick, MD, USA.
  • Larson PA; Center for Genome Sciences, United States Army Medical Research Institute of Infectious Diseases, Frederick, MD, USA.
  • Beitzel B; Center for Genome Sciences, United States Army Medical Research Institute of Infectious Diseases, Frederick, MD, USA.
  • Ayouba A; TransVIHMI, Institut de Recherche pour le Développement, Institut National de la Santé et de la Recherche Médicale, Université de Montpellier, Montpellier, France.
  • Vidal N; TransVIHMI, Institut de Recherche pour le Développement, Institut National de la Santé et de la Recherche Médicale, Université de Montpellier, Montpellier, France.
  • Karhemere S; Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo.
  • Diop M; Institut Pasteur de Dakar, Dakar, Senegal.
  • Diagne MM; Institut Pasteur de Dakar, Dakar, Senegal.
  • Faye M; Institut Pasteur de Dakar, Dakar, Senegal.
  • Faye O; Institut Pasteur de Dakar, Dakar, Senegal.
  • Aruna A; Direction Générale de Lutte contre la Maladie, Kinshasa, Democratic Republic of the Congo.
  • Nsio J; Direction Générale de Lutte contre la Maladie, Kinshasa, Democratic Republic of the Congo.
  • Mulangu F; Direction Générale de Lutte contre la Maladie, Kinshasa, Democratic Republic of the Congo.
  • Mukadi D; Service de Microbiologie, Cliniques Universitaires de Kinshasa, Kinshasa, Democratic Republic of the Congo.
  • Mukadi P; Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo.
  • Kombe J; Direction Générale de Lutte contre la Maladie, Kinshasa, Democratic Republic of the Congo.
  • Mulumba A; l'Organisation Mondiale de la Santé, Kinshasa, Democratic Republic of the Congo.
  • Villabona-Arenas CJ; Centre for the Mathematical Modelling of Infectious Diseases, London School of Hygiene & Tropical Medicine, London, UK.
  • Pukuta E; Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo.
  • Gonzalez J; Center for Genome Sciences, United States Army Medical Research Institute of Infectious Diseases, Frederick, MD, USA.
  • Bartlett ML; Center for Genome Sciences, United States Army Medical Research Institute of Infectious Diseases, Frederick, MD, USA; Department of Pathology and Microbiology, Northern Arizona University, Flagstaff, AZ, USA.
  • Sozhamannan S; Defense Biological Product Assurance Office, Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense-Joint Project Management Office for Guardian, Frederick, MA, USA; The Tauri Group, Alexandria, VA, USA.
  • Gross SM; Illumina, San Diego, CA, USA.
  • Schroth GP; Illumina, San Diego, CA, USA.
  • Tim R; Illumina, San Diego, CA, USA.
  • Zhao JJ; Illumina, San Diego, CA, USA.
  • Kuhn JH; Integrated Research Facility at Fort Detrick, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, MD, USA.
  • Diallo B; World Health Organization, Geneva, Switzerland.
  • Yao M; World Health Organization, Geneva, Switzerland.
  • Fall IS; World Health Organization, Geneva, Switzerland.
  • Ndjoloko B; Direction Générale de Lutte contre la Maladie, Kinshasa, Democratic Republic of the Congo.
  • Mossoko M; Direction Générale de Lutte contre la Maladie, Kinshasa, Democratic Republic of the Congo.
  • Lacroix A; TransVIHMI, Institut de Recherche pour le Développement, Institut National de la Santé et de la Recherche Médicale, Université de Montpellier, Montpellier, France.
  • Delaporte E; TransVIHMI, Institut de Recherche pour le Développement, Institut National de la Santé et de la Recherche Médicale, Université de Montpellier, Montpellier, France.
  • Sanchez-Lockhart M; Center for Genome Sciences, United States Army Medical Research Institute of Infectious Diseases, Frederick, MD, USA; Department of Pathology and Microbiology, Northern Arizona University, Flagstaff, AZ, USA.
  • Sall AA; Institut Pasteur de Dakar, Dakar, Senegal.
  • Muyembe-Tamfum JJ; Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo; Service de Microbiologie, Cliniques Universitaires de Kinshasa, Kinshasa, Democratic Republic of the Congo.
  • Peeters M; TransVIHMI, Institut de Recherche pour le Développement, Institut National de la Santé et de la Recherche Médicale, Université de Montpellier, Montpellier, France.
  • Palacios G; Center for Genome Sciences, United States Army Medical Research Institute of Infectious Diseases, Frederick, MD, USA. Electronic address: gustavo.f.palacios.civ@mail.mil.
  • Ahuka-Mundeke S; Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo; Service de Microbiologie, Cliniques Universitaires de Kinshasa, Kinshasa, Democratic Republic of the Congo.
Lancet Infect Dis ; 19(6): 648-657, 2019 06.
Article em En | MEDLINE | ID: mdl-31000464
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antivirais / Doença pelo Vírus Ebola / Genômica / Vacinas contra Ebola / Ebolavirus / Anticorpos Monoclonais Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans País como assunto: Africa Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Antivirais / Doença pelo Vírus Ebola / Genômica / Vacinas contra Ebola / Ebolavirus / Anticorpos Monoclonais Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans País como assunto: Africa Idioma: En Ano de publicação: 2019 Tipo de documento: Article